Research library / Longevity compounds
CC Small or few human trials. Promising, not proven. How we grade →RCT (double-blind, placebo-controlled) · 50 adults aged 40 to 64 with obesity, 4 weeks
Urolithin A and Endothelial and Cerebrovascular Function in Middle-Aged Adults With Obesity: A Randomized Clinical Trial
A da Costa Pinaffi-Langley, R Gulej, Z Kaposzta, Z Szarvas, A Shahriari, H Kinnard et al. JAMA Network Open. 2026.
- In plain language
- 1,000 mg a day did not improve artery function (the main goal) or other blood vessel measures; brain blood flow responses during a task were larger, task performance unchanged.
- Limits
- Small, 4 weeks, 7 lost to follow-up; independent funding (American Heart Association, Reynolds Foundation).
- Which of our grades it feeds
- CC Small or few human trials. Promising, not proven. How we grade →Science summary: Urolithin A and mitochondria
- Source
- doi.org/10.1001/jamanetworkopen.2026.38047 · PubMed 42853569 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.